Cargando...
Anticoagulants, Antiplatelets, and Thrombolytics
Featuring a collection of review articles that highlights the development of antithrombotics, this work provides experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, s...
Autor principal: | |
---|---|
Formato: | Printed Book |
Publicado: |
Totowa
HUMANA PRESS
2004
|
Colección: | Methods in Molecular Medicine, 93
|
Materias: | |
Acceso en línea: | http://classify.oclc.org/classify2/ClassifyDemo?owi=895365339 |
LEADER | 01046nam a2200181 4500 | ||
---|---|---|---|
999 | |c 123120 |d 123116 | ||
020 | |a 9781588290830 | ||
082 | |a 615. 718 MOU/A | ||
100 | |a Mousa, Shaker ; Ed. |9 59170 | ||
245 | |a Anticoagulants, Antiplatelets, and Thrombolytics | ||
260 | |a Totowa |b HUMANA PRESS |c 2004 | ||
300 | |a 307p. | ||
490 | |a Methods in Molecular Medicine, 93 | ||
520 | |a Featuring a collection of review articles that highlights the development of antithrombotics, this work provides experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as the hirudin. | ||
650 | |a Anticoagulants (Medicine) Blood platelets --Thrombolytic therapy. |9 59171 | ||
856 | |u http://classify.oclc.org/classify2/ClassifyDemo?owi=895365339 | ||
942 | |c BK | ||
952 | |0 0 |1 0 |4 0 |6 615_000000000000000__718_MOU_A |7 0 |9 119852 |a SBS |b SBS |d 2017-08-17 |l 0 |o 615. 718 MOU/A |p SBS1759 |r 2017-08-17 |w 2017-08-17 |y BK |